• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用2-[18F]-氟-2-脱氧-D-葡萄糖进行全身正电子发射断层扫描可检测复发性卵巢癌。

Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma.

作者信息

Karlan B Y, Hawkins R, Hoh C, Lee M, Tse N, Cane P, Glaspy J

机构信息

Division of Gynecologic-Oncology, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

Gynecol Oncol. 1993 Nov;51(2):175-81. doi: 10.1006/gyno.1993.1268.

DOI:10.1006/gyno.1993.1268
PMID:8276290
Abstract

The existing means of detecting recurrent ovarian carcinoma are notoriously poor. Positron emission tomography (PET) is a form of computer-assisted imaging which produces images reflective of the biochemistry of the tissues rather than their physical characteristics. PET imaging with the positron emitting glucose analog 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) exploits the accelerated rate of glycolysis characteristic of malignant tissue to image tumors. To begin to study PET's ability to diagnose recurrent ovarian cancer, whole-body PET FDG scanning was performed on 13 patients prior to planned surgical exploration. Seven patients were suspected of having recurrence based upon clinical findings, and 6 patients were clinically free of disease. In all 6 of the patients with suspected recurrence who subsequently underwent surgery, PET images demonstrated increased FDG uptake in a distribution that correlated with surgical-pathologic findings. Both intraperitoneal and extraperitoneal lesions were detected by PET. All 6 patients judged clinically free of disease had negative PET scans, but in 5 of these microscopic foci of residual tumor were found at surgery. Although PET FDG cannot replace surgery in the detection of microscopic recurrence, it can accurately detect tumors greater than 1.0 cm in diameter.

摘要

现有的复发性卵巢癌检测手段 notoriously 较差。正电子发射断层扫描(PET)是一种计算机辅助成像形式,它生成的图像反映的是组织的生物化学特性而非其物理特征。使用发射正电子的葡萄糖类似物2-[18F]-氟-2-脱氧-D-葡萄糖(FDG)进行PET成像利用了恶性组织特有的糖酵解加速速率来对肿瘤进行成像。为了开始研究PET诊断复发性卵巢癌的能力,在计划进行手术探查前,对13例患者进行了全身PET FDG扫描。7例患者根据临床发现怀疑有复发,6例患者临床上无疾病。在随后接受手术的所有6例疑似复发患者中,PET图像显示FDG摄取增加,其分布与手术病理结果相关。PET检测到了腹膜内和腹膜外病变。所有6例临床上判断无疾病的患者PET扫描均为阴性,但其中5例在手术中发现了残留肿瘤的微小病灶。虽然PET FDG在检测微小复发方面不能替代手术,但它能准确检测直径大于1.0厘米的肿瘤。

相似文献

1
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma.采用2-[18F]-氟-2-脱氧-D-葡萄糖进行全身正电子发射断层扫描可检测复发性卵巢癌。
Gynecol Oncol. 1993 Nov;51(2):175-81. doi: 10.1006/gyno.1993.1268.
2
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.卵巢癌复发:使用2-[氟-18]-氟-2-脱氧-D-葡萄糖的全身正电子发射断层扫描的作用
Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):797-803. doi: 10.1007/s00259-001-0750-9. Epub 2002 Mar 19.
3
Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
J Reprod Med. 1999 Sep;44(9):775-8.
4
Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.18F-氟代脱氧葡萄糖全身正电子发射断层扫描用于复发性卵巢癌的检测。
Anticancer Res. 2001 Sep-Oct;21(5):3691-4.
5
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.2-[氟-18]-氟-2-脱氧-D-葡萄糖正电子发射断层扫描在复发性卵巢癌诊断中的应用
Gynecol Oncol. 2001 Nov;83(2):310-5. doi: 10.1006/gyno.2001.6386.
6
Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.采用 2-[F-18]氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描技术对血清 CA-125 水平轻度升高的患者进行复发性卵巢癌的早期检测。
Cancer Biother Radiopharm. 2011 Apr;26(2):175-81. doi: 10.1089/cbr.2010.0872. Epub 2011 Apr 21.
7
[Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose].[利用正电子发射断层扫描和F-18氟脱氧葡萄糖对卵巢肿瘤进行代谢特征分析]
Rofo. 1997 Jan;166(1):62-8. doi: 10.1055/s-2007-1015379.
8
Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.使用2-[¹⁸F]氟-2-脱氧-D-葡萄糖进行全身PET癌症检测。
J Comput Assist Tomogr. 1993 Jul-Aug;17(4):582-9. doi: 10.1097/00004728-199307000-00012.
9
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).通过F-18氟脱氧葡萄糖正电子发射断层扫描(FDG PET)检测原发性和复发性肺癌。
J Thorac Cardiovasc Surg. 1995 Jul;110(1):130-9; discussion 139-40. doi: 10.1016/S0022-5223(05)80018-2.
10
[Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma].
Zhonghua Fu Chan Ke Za Zhi. 2002 Jun 18;37(6):356-8.

引用本文的文献

1
The role of F-FDG PET CT in common gynaecological malignancies.F-FDG PET CT在常见妇科恶性肿瘤中的作用。
Br J Radiol. 2017 Nov;90(1079):20170283. doi: 10.1259/bjr.20170283. Epub 2017 Aug 22.
2
An update on the role of PET/CT and PET/MRI in ovarian cancer.正电子发射断层扫描/计算机断层扫描(PET/CT)和正电子发射断层扫描/磁共振成像(PET/MRI)在卵巢癌中作用的最新进展。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1079-1091. doi: 10.1007/s00259-017-3638-z. Epub 2017 Feb 8.
3
Analysis of positron emission tomography/computed tomography in patients to differentiate between malignant transformation of endometrioma and endometrioma.
正电子发射断层扫描/计算机断层扫描在患者中用于鉴别子宫内膜异位囊肿恶变与子宫内膜异位囊肿的分析。
Int J Clin Oncol. 2016 Dec;21(6):1136-1141. doi: 10.1007/s10147-016-1013-x. Epub 2016 Jul 5.
4
Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma.氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)在铂敏感型上皮性卵巢癌随访中的诊断准确性
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1396-405. doi: 10.1007/s00259-007-0366-9. Epub 2007 Feb 21.
5
18F-fluorodeoxyglucose positron emission tomography in patients with recurrent ovarian cancer: in comparison with vascularity, Ki-67, p53, and histologic grade.18F-氟脱氧葡萄糖正电子发射断层扫描在复发性卵巢癌患者中的应用:与血管生成、Ki-67、p53及组织学分级的比较
Eur Radiol. 2007 Feb;17(2):409-17. doi: 10.1007/s00330-006-0326-y. Epub 2006 Jun 20.
6
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
Int J Clin Oncol. 2005 Jun;10(3):177-81. doi: 10.1007/s10147-005-0489-6.
7
Effectiveness of positron emission tomography for the detection of melanoma metastases.正电子发射断层扫描在检测黑色素瘤转移灶方面的有效性。
Ann Surg. 1998 May;227(5):764-9; discussion 769-71. doi: 10.1097/00000658-199805000-00017.
8
Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images.临床肿瘤学中的全身正电子发射断层扫描:衰减校正图像与未校正图像的比较。
Eur J Nucl Med. 1997 Sep;24(9):1091-8. doi: 10.1007/BF01254239.
9
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Eur J Nucl Med. 1997 Jun;24(6):691-705. doi: 10.1007/BF00841411.
10
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.正电子发射断层扫描结合氟-18氟脱氧葡萄糖在肿瘤学中的应用。
Eur J Nucl Med. 1996 Dec;23(12):1641-74. doi: 10.1007/BF01249629.